Moderators: Eloisa Bonfá (Brazil) & David Isenberg (UK) | ||
08:30 | Disease activity and treatment targets in SLE Q&A and Discussion (10 Mins) | Luís Ines (Portugal) |
08:55 | Molecular signatures in kidney biopsies and their relationship to clinical activity Q&A and Discussion (10 Mins) | Jill Buyon (USA) |
09:20 | What drives rapid progression to ESRD in patients with lupus nephritis? Q&A and Discussion (10 Mins) | Murray Urowitz (Canada) |
09:45 | Increased CV risk in women with SLE: Stories from a panel of biomarkers Q&A and Discussion (10 Mins) | Matteo Piga (Italy) |
10:10 | Panel Discussion (20 Mins) | |
10:30 | Break |